Healthcare Innovation March 1, 2019
David Raths

Consortium seeks to expand access to high-quality clinical whole genome sequencing for genetic diseases

Eight U.S and Canadian healthcare organizations, researchers and vendors have launched a consortium that will work to expand access to high-quality clinical whole genome sequencing (cWGS) for the diagnosis of genetic diseases.

The Medical Genome Initiative will focus on the publication of common laboratory and clinical best practices for the application of cWGS. Founding members include Baylor Genetics; Broad Institute of MIT and Harvard; HudsonAlpha Institute for Biotechnology; Illumina Inc.; Mayo Clinic; Rady Children’s Institute for Genomic Medicine; The Hospital for Sick Children (SickKids Toronto); and Stanford Medicine.

Rare genetic diseases affect more than 350 million people globally and are a particularly significant source of morbidity...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Precision Medicine, Technology
Former Bristol Myers CEO tapped as Novartis’ next board chair
The Power of Drug Discovery with Philip Tagari
Novartis raises forecasts as top drug sales beat Wall Street estimates
Pharma Pulse 4/23/24: Drug Discount Programs Poised to Change with New Tech, SpecialtyRx Savings Navigator to Enhance Affordability & more
AI Ushers in HPC Revival Says TACC’s Dan Stanzione

Share This Article